Ms. Keck leads the Blue Cross Blue Shield Association as its first female CEO, unifying 33 independent Blue Cross and Blue Shield companies around a shared mission to improve affordability, access and experience for nearly 116 million Americans. In her five years at the helm, she has steered the Blue System toward bold action on healthcare policy reform, including advocacy for fair hospital billing and addressing practices that drive up drug costs. In 2025, she helped mobilize Blue Plans and industry leaders to commit to six major actions to improve the prior authorization experience for more than 257 million patients and providers, advancing digital capabilities designed to meet and exceed interoperability standards by 2027. Her forward-looking approach to technology has led to partnerships with OpenAI and Anthropic to bring secure, scalable enterprise GPT capabilities to all 33 plans. She was also instrumental in advancing generative AI pilots to provide a promising agentic AI solution for federal employees covered under the federal employee program. Under her stewardship, the program achieved its 40th consecutive year of growth and maintained a 99%-plus retention rate, while launching initiatives expected to generate over $1 billion in specialty pharmacy savings for members. Ms. Keck serves as board chairperson of Synergie Medication Collective and as a board member of HarmonyCares, Evolent Health and BCS Financial. She was recognized as a “CNBC Changemaker” in 2025.
